For his research on the potential of gene therapy to provide lasting control of intraocular pressure in glaucoma patients with known genetic defects, András Komáromy, DVM, PhD was awarded the 2015 Shaffer Prize for Innovative Glaucoma Research. (glaucoma.org)
Glaucoma is the term used to describe a group of conditions that result in increased intraocular pressure, with damage to the retinal ganglion cells and their axons, leading to vision loss and blindness. (cgejournal.biomedcentral.com)
Intravitreous injections of anti-VEGF agents may increase the risk of elevated intraocular pressure (IOP); however, the risk of developing moderate to advanced glaucoma requiring glaucoma surgery has been unclear. (sciencedaily.com)